Here is what all four major STEP trials showed: Breakthrough finding from OASIS 4: The oral Wegovy pill (25mg semaglutide) achieved 16.6% mean weight loss at 64 weeks with full adherence outperforming the injectable Wegovy in its primary trial
If you have diagnosed Cushing's syndrome or severe adrenal insufficiency, discuss GLP-1 therapy with your endocrinologist before starting
Understanding what Aetna requires makes approval much more likely
Le produit est apprci pour sa combinaison de L-carnitine et de chrome, qui aide maintenir un mtabolisme normal
It is thought that portal hypertension (high blood pressure in the livers venous system) due to NAFLD may impair the kidneys ability to regulate sodium levels and blood pressure, triggering dysfunctional compensatory mechanisms and setting the stage for CKD
Disclosure of interest: All of authors: nothing to disclose Poster Session II - DIGITAL TRANSFORMATION, AI AND ROBOTICS 07.00 - DIGITAL TRANSFORMATION, AI AND ROBOTICS - 07.01 - TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE P895 - ESOC25-2267 COMPARING MACHINE LEARNING MODELS FOR DIFFERENTIATING STROKE SUBTYPES USING BIOMARKERS AND IMAGING MODALITIES Manabesh Nath 1 , Pradeep Kumar 2 , Shubham Misra 3 , Manjari Tripathi 1 , Sachin Kumar 4 , Shantanu Sengupta 5 , Awadh Pandit 1 , Deepti Vibha 1 1 Department of Neurology All India Institute of Medical Sciences, Neurosciences Centre, New Delhi, India, 2 Clinical Research Unit, All India Institute of Medical Sciences, New Delhi, India, 3 Department of Neurology, Yale University, New Haven, United States, 4 Center for Biomedical Engineering, Indian Institute of Technology, New Delhi, India, 5 Institute of Genomics and Integrative Biology, New Delhi, India Background and Aims: Accurate and rapid stroke subtype differentiation is crucial for effective treatment
